This study hypothesized that metformin mitigates DN progression by modulating immunosenescence and the FABP4/FOXO1 pathway, which is closely linked to macrophage activation and polarization—key processes in DN progression. This evidence concerns the gene FABP4 and liver dysplastic nodule.